GSK plc – NYSE:GSK

GSK stock price today

$39.306
+5.22
+15.33%
Financial Health
0
1
2
3
4
5
6
7
8
9

GSK stock price monthly change

-12.97%
month

GSK stock price quarterly change

-12.97%
quarter

GSK stock price yearly change

-8.14%
year

GSK key metrics

Market Cap
68.72B
Enterprise value
68.15B
P/E
44.03
EV/Sales
2.17
EV/EBITDA
7.53
Price/Sales
1.76
Price/Book
7.89
PEG ratio
16.24
EPS
1.10
Revenue
30.74B
EBITDA
9.93B
Income
4.48B
Revenue Q/Q
5.92%
Revenue Y/Y
5.69%
Profit margin
8.02%
Oper. margin
16.64%
Gross margin
72.05%
EBIT margin
16.64%
EBITDA margin
32.33%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

GSK stock price history

GSK stock forecast

GSK financial statements

GSK plc (NYSE:GSK): Profit margin
Jun 2023 7.17B 1.62B 22.62%
Sep 2023 8.14B 1.46B 17.97%
Dec 2023 8.05B 350M 4.35%
Mar 2024 7.36B 1.04B 14.21%
GSK plc (NYSE:GSK): Analyst Estimates
Dec 2023 8.05B 350M 4.35%
Mar 2024 7.36B 1.04B 14.21%
Sep 2025 11.51B 4.44B 38.63%
Dec 2025 11.13B 2.59B 23.34%
  • Analysts Price target

  • Financials & Ratios estimates

GSK plc (NYSE:GSK): Earnings per share (EPS)
2022-11-02 0.937 1.1
2023-02-01 0.4819 0.61
2023-04-26 0.813 0.9
3.63%
Yield TTM
GSK plc (NYSE:GSK): Payout ratio
Payout ratio 95.58%
GSK plc (NYSE:GSK): Dividend Yield
2019 5.64%
2020 7.42%
2021 7.67%
2022 5.93%
2023 1.88%
GSK plc (NYSE:GSK): Debt to assets
Jun 2023 59461000000 47.30B 79.55%
Sep 2023 60862000000 48.24B 79.27%
Dec 2023 59005000000 46.21B 78.32%
Mar 2024 58511000000 45.28B 77.39%
GSK plc (NYSE:GSK): Cash Flow
Jun 2023 1.30B -964M 31M
Sep 2023 2.21B -491M -1.76B
Dec 2023 2.97B 207M -3.30B
Mar 2024 939M -201M -989M

GSK alternative data

GSK plc (NYSE:GSK): Employee count
Aug 2023 69,400
Sep 2023 69,400
Oct 2023 69,400
Nov 2023 69,400
Dec 2023 69,400
Jan 2024 69,400
Feb 2024 69,400
Mar 2024 70,212
Apr 2024 70,212
May 2024 70,212
Jun 2024 70,212
Jul 2024 70,212

GSK other data

6.71% +0.17%
of GSK is owned by hedge funds
339.76M +8.62M
shares is hold by hedge funds
Insider Compensation
Dr. Hal V. Barron F.A.C.C., M.D. (1963) Chief Scientific Officer, Pres of R&D and Director
$4,830,000
Ms. Emma N. Walmsley (1970) Chief Executive Officer & Director $3,730,000
Mr. Iain James Mackay (1962) Chief Financial Officer & Executive Director
$2,730,000
Friday, 20 December 2024
proactiveinvestors.co.uk
reuters.com
Tuesday, 17 December 2024
zacks.com
Monday, 16 December 2024
proactiveinvestors.co.uk
Wednesday, 11 December 2024
zacks.com
Tuesday, 10 December 2024
globenewswire.com
globenewswire.com
Monday, 9 December 2024
proactiveinvestors.com
reuters.com
zacks.com
Friday, 6 December 2024
youtube.com
Thursday, 5 December 2024
zacks.com
proactiveinvestors.co.uk
wsj.com
reuters.com
Thursday, 28 November 2024
zacks.com
Wednesday, 27 November 2024
https://www.proactiveinvestors.com
proactiveinvestors.co.uk
Tuesday, 26 November 2024
zacks.com
Monday, 25 November 2024
proactiveinvestors.co.uk
Friday, 22 November 2024
proactiveinvestors.co.uk
https://www.proactiveinvestors.com
reuters.com
Wednesday, 20 November 2024
zacks.com
Tuesday, 19 November 2024
invezz.com
proactiveinvestors.co.uk
reuters.com
Monday, 18 November 2024
proactiveinvestors.com
Friday, 15 November 2024
forbes.com
seekingalpha.com
  • What's the price of GSK stock today?

    One share of GSK stock can currently be purchased for approximately $39.31.

  • When is GSK's next earnings date?

    Unfortunately, GSK's (GSK) next earnings date is currently unknown.

  • Does GSK pay dividends?

    Yes, GSK pays dividends and its trailing 12-month yield is 3.63% with 96% payout ratio. The last GSK stock dividend of $0.52 was paid on 13 Jan 2022.

  • How much money does GSK make?

    GSK has a market capitalization of 68.72B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3.42% to 30.33B US dollars. GSK earned 4.93B US dollars in net income (profit) last year or $0.9 on an earnings per share basis.

  • What is GSK's stock symbol?

    GSK plc is traded on the NYSE under the ticker symbol "GSK".

  • What is GSK's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - General industry.

  • How do i buy shares of GSK?

    Shares of GSK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are GSK's key executives?

    GSK's management team includes the following people:

    • Dr. Hal V. Barron F.A.C.C., M.D. Chief Scientific Officer, Pres of R&D and Director(age: 62, pay: $4,830,000)
    • Ms. Emma N. Walmsley Chief Executive Officer & Director(age: 55, pay: $3,730,000)
    • Mr. Iain James Mackay Chief Financial Officer & Executive Director(age: 63, pay: $2,730,000)
  • How many employees does GSK have?

    As Jul 2024, GSK employs 70,212 workers.

  • When GSK went public?

    GSK plc is publicly traded company for more then 45 years since IPO on 28 Mar 1980.

  • What is GSK's official website?

    The official website for GSK is gsk.com.

  • How can i contact GSK?

    GSK can be reached via phone at +44 20 8047 5000.

GSK company profile:

GSK plc

gsk.com
Exchange:

NYSE

Full time employees:

70,212

Industry:

Drug Manufacturers - General

Sector:

Healthcare

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

980 Great West Road
Brentford, TW8 9GS

CIK: 0001131399
ISIN: US37733W2044
CUSIP: 37733W204